Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robak

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
British Journal of Haematology|April 28, 2001
Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, M Kasznicki, J Z Bloński, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 27, 2004
The inhibitor of apoptosis protein family and its antagonists in acute leukemiasA Wrzesień-Kuś, P Smolewski, A Sobczak-Pluta, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|November 21, 1988
[Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide]T Robak, E Krykowski, W Matusewicz, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|March 14, 1988
[Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences]T Robak, E Krykowski, W Matusewicz, et al.
Journal of Medicine|January 1, 1997
2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemiaT Robak, A Sysa-Jedrzejowska, E Robak, et al.
Kardiologia Polska|January 1, 1989
[Ventricular fibrillation in a patient with myelodysplastic syndrome treated with small doses of cytarabine]J Drzewoski, E Krykowski, T Robak, et al.
Leukemia & Lymphoma|April 1, 1997
Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three casesM Blasińska-Morawiec, T Robak, E Krykowski, et al.
Chemotherapy|August 10, 2005
Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignanciesT Robak, A Szmigielska-Kapłon, J Z Błoński, et al.
Leukemia|March 17, 2006
The role of p73 in hematological malignanciesA Pluta, U Nyman, B Joseph, et al.
Leukemia & Lymphoma|September 7, 2000
Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemiaT Robak, A Wrzesień-Kuś, E Lech-Marańda, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
British Journal of Haematology|April 28, 2001
Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, M Kasznicki, J Z Bloński, et al.
Apoptosis : an International Journal on Programmed Cell Death|October 27, 2004
The inhibitor of apoptosis protein family and its antagonists in acute leukemiasA Wrzesień-Kuś, P Smolewski, A Sobczak-Pluta, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|November 21, 1988
[Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide]T Robak, E Krykowski, W Matusewicz, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|March 14, 1988
[Large doses of cytarabine, etoposide and methotrexate (CEM protocol) in the treatment of lymphoblastic leukemia in adults, resistant to conventional treatment, and of recurrences]T Robak, E Krykowski, W Matusewicz, et al.
Journal of Medicine|January 1, 1997
2-chlorodeoxyadenosine (cladribine) induced allergic cutaneous reactions with eosinophilia in a patient with B-cell chronic lymphocytic leukemiaT Robak, A Sysa-Jedrzejowska, E Robak, et al.
Kardiologia Polska|January 1, 1989
[Ventricular fibrillation in a patient with myelodysplastic syndrome treated with small doses of cytarabine]J Drzewoski, E Krykowski, T Robak, et al.
Leukemia & Lymphoma|April 1, 1997
Hairy cell leukemia-variant treated with 2-chlorodeoxyadenosine--a report of three casesM Blasińska-Morawiec, T Robak, E Krykowski, et al.
Chemotherapy|August 10, 2005
Activity of cladribine combined with etoposide in heavily pretreated patients with indolent lymphoid malignanciesT Robak, A Szmigielska-Kapłon, J Z Błoński, et al.
Leukemia|March 17, 2006
The role of p73 in hematological malignanciesA Pluta, U Nyman, B Joseph, et al.
Leukemia & Lymphoma|September 7, 2000
Combination regimen of cladribine (2-chlorodeoxyadenosine), cytarabine and G-CSF (CLAG) as induction therapy for patients with relapsed or refractory acute myeloid leukemiaT Robak, A Wrzesień-Kuś, E Lech-Marańda, et al.
Pageof 30